Treatment of Status Epilepticus with a new Benzodiazepine More Active than Diazepam*
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
SUMMARY: A new benzodiazepine, number RO 05–4023 (Hoffmann‐La Roche) was used to treat 39 episodes of status in 37 patients. The episodes of status occurred in established epileptics in 28 instances and were of the following types: 9 generalized convulsions, 12 generalized non‐convulsive episodes (absence status), 5 unilateral convulsions, and 2 partial somato‐motor convulsions. The remaining 11 episodes of status were of organic origin or medicine‐induced in non‐epileptic patients. Each patient was treated by intravenous injection or occasionally by perfusion of RO 05–4023, almost always during and after polygraphic recording of the electroencephalogram, electrocardiogram, electromyogram and respiration. Of the 39 episodes of status treated, there was only 1 relative failure. The effective doses were minimal: 1 mg or less in 25 cases, 2 mg in 8, 3 mg in 2, 6 mg in 1, and 8 mg by perfusion in 2 cases. Control was effected within 1 min as a rule. Some of the episodes of status had not been controlled by large doses of the ordinary anticonvulsants: phenobarbital 120 mg in 1 case, diazepam 30 mg in another. There were no unfavourable side‐effects, but the substance is of course effective on the status proper and not on the cause. In our experience RO 05–4023 is the most effective substance available at present for the treatment of status epilepticus. RÉSUMÉ: Les auteurs rapportent leur expérience du traitement des états de mal épileptiques par une nouvelle benzodiazepine, le RO 05 4023 (Laboratoires ROCHE). Leur materiel comporte 39 états de mal survenus chez des épileptiques avérés et se subdivisant en 9 états de mal généralisés convulsifs, 12 états de mal généralisés non convulsifs (états d'absences), 5 états de mal unilatéraux, 2 états de mal partiels, somato‐moteurs. Par ailleurs, 11 états de mal (d'origine iatrogène ou organique) survenus chez des sujets non epileptiques complètent la série. Chaque sujet a été traité par injection intra‐veineuse directe ou exceptionnellement par perfusion du produit, presque toujours avec contrôle polygraphique pendant et après l'injection (électroencéphalogramme, électrocardiogramme, électromyo‐gramme, respiration). Sur les 39 états de mal traités, nous n'avons observé qu'un échec relatif. Les doses efficaces ont été minimes: 1 mg ou moins dans 25 cas; 2 mg dans 8; 3 mg dans 2; 6 mg dans 1; 8 mg en perfusion dans 2. L'effet bénéfique a été obtenu dans un délai de l'ordre de la minute. Certains de ces états de mal avaient résisté aux autres thérapeutiques habituellement utilisées à des doses parfois considérables (120 mg de Gardénal sodique dans un cas, 30 mg de Valium dans un autre). Aucun effet secondaire défavorable n'a été observé, mais le produit n'agit, bien‐entendu, que sur l'état de mal proprement dit et non sur ses causes. Pour les auteurs, le RO 05 4023 est actuellement le produit le plus efficace dont nous disposons dans le traitement des états de mal épileptiques.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GASTAUT, H., ROGER, J., SOULAYROL, R., TASSINARI, C. A., RÉGIS, H., DRAVET, C., BERNARD, R., PINSARD, N., & SAINT‐JEAN, M. (1966) · Epilepsia · doi:10.1111/j.1528-1167.1966.tb06263.x · Cited by 431
Self-citation
Cited by
Antiepileptic Drugs as a Cause of Worsening Seizures
Perucca, E., Gram, L., Avanzini, G., & Dulac, O. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01268.x · Cited by 543
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
Antiepileptic drug therapy the story so far
Brodie, M. J. (2010) · Seizure · doi:10.1016/j.seizure.2010.10.027 · Cited by 298
Pharmacokinetic Optimisation of Benzodiazepine Therapy for Acute Seizures: Focus on Delivery Routes
Rey, E., Tr??luyer, J.-M., & Pons, G. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00003 · Cited by 265
“[1] The response to intravenous clonazepam[2] and midazolam[3] was rapid, within 1 minute for both drugs.”
BackgroundKienitz, R., Kay, L., Beuchat, I., Gelhard, S., von Brauchitsch, S., Mann, C., Lucaciu, A., Schäfer, J.-H., Siebenbrodt, K., Zöllner, J.-P., et al. (2022) · CNS Drugs · doi:10.1007/s40263-022-00940-2 · Cited by 139
“Since the first clinical publication by Gastaut in 1971 [142], few clinical trials have been conducted to evaluate the efficacy of CZP for SE.”
Background
Metadata
- Authors
- GASTAUT, H., COURJON, J., POIRE, R., & WEBER, M.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 1971-09
- Volume
- 12
- Issue
- 3
- Pages
- 197-214
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2106025389
- Cited by
- 82
- References
- 1
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Status Epilepticus with a new Benzodiazepine More Active than Diazepam*. https://app.cochat.ai/papers/10.1111/j.1528-1157.1971.tb04928.x
- The paper
- GASTAUT, H., COURJON, J., POIRE, R., & WEBER, M. (1971). Treatment of Status Epilepticus with a new Benzodiazepine More Active than Diazepam*. Epilepsia. https://doi.org/10.1111/j.1528-1157.1971.tb04928.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.